Sascha Manthei

Title: Sascha Manthei: Innovator in Depression Treatment

Introduction

Sascha Manthei is a notable inventor based in Pratteln, Switzerland. He has made significant contributions to the field of mental health, particularly in the treatment of depression. With a total of 3 patents to his name, Manthei's work focuses on innovative methods for administering ketamine to patients suffering from depression and bipolar disorder.

Latest Patents

Manthei's latest patents include a "Method for treatment of depression with oral dosage forms of ketamine." This invention relates to an oral dosage form for the administration of ketamine and outlines a method for preparing this form, ideally to be taken once or twice a day. Another significant patent is the "Method for treating depression," which addresses treatment for patients who have not responded to traditional antidepressants. This method aims to avoid dose dumping upon ingestion of alcohol and also involves an oral dosage form for ketamine.

Career Highlights

Throughout his career, Sascha Manthei has worked with reputable companies such as Develco Pharma Schweiz AG and Ketabon GmbH. His experience in these organizations has allowed him to develop and refine his innovative approaches to mental health treatment.

Collaborations

Manthei has collaborated with professionals in the field, including Helene Rey and Marc Fischer. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Sascha Manthei's work in the field of depression treatment through innovative methods of ketamine administration showcases his dedication to improving mental health care. His patents reflect a commitment to finding effective solutions for patients in need.